MedTrace Logo

Efficacy of the Unified Protocol for the Transdiagnostic Treatment (UP-A; Ehrenreich-May et al., 2018) for Adolescents With Moderate Emotional Symptoms in Educational Settings

NCT05322642 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-04-13

No results posted yet for this study

Summary

The main goal is to assess the efficacy of the Unified Protocol for the Transdiagnostic Treatment (UP-A; Ehrenreich-May et al., 2018) for Adolescents with moderate emotional symptoms in educational settings The goal is to prevent emotional symptoms and improve the socio-emotional adjustment.

Conditions

  • Anxiety Disorder
  • Depressive Disorder
  • Emotional Problem
  • Emotional Disorder

Interventions

BEHAVIORAL

UPA

UP-A is divided into five main treatment modules and three optional modules. The UP-A seek to positively affect how adolescents with anxiety and/ or depression experiences, think about, and respond to a broad range of negative and positive emotions, rather than disorder-specific emotions (e.g., fear, sadness).

BEHAVIORAL

Active control condition (Progressive Relaxation Training)

Progressive Relaxation Training (Bernstein and Borkovec) program is divided in ten sessions. Relaxation training often is used in behavior therapy as a means to reduce anxiety, tension, and stress. The goal is to release tension from your muscles, while helping you recognize what that tension feels like.

Sponsors & Collaborators

  • Psicofundación: Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicolo

    collaborator OTHER

  • Consejo General de la Psicología de España

    collaborator UNKNOWN

  • Eduardo Fonseca Pedrero

    lead OTHER

Principal Investigators

  • Eduardo Fonseca Pedrero, PhD · University of La Rioja

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-07-01
Completion
2024-01-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05322642 on ClinicalTrials.gov